Prøve GULL - Gratis

Asia Labex showcases latest advancements in lab technology

Chronicle Pharmabiz

|

October 30, 2025

DRIVEN by increased investment in pharmaceutical and biotech R&D, a rising need for advanced diagnostic equipment due to disease prevalence, and the growing adoption of automation in labs, the pharma laboratory equipment market has positive prospects.

- Our Bureau, Mumbai

The Indian pharma laboratory equipment market is taking rapid strides, driven by technological advancements and evolving regulatory landscapes. With advancements in technology, increasing demand for precision, and the need for enhanced efficiency in laboratories, the lab automation market is witnessing transformative growth.

The market is set to grow at a steady pace, with major opportunities in emerging regions like Asia-Pacific and the increased adoption of automated systems in clinical diagnostics, research, and environmental testing.

The integration of advanced technologies and the drive for sustainable practices will be key factors influencing the market's future trajectory.

The Lab 4.0 paradigm is reshaping laboratory operations by embedding digital technologies throughout research workflows.

Asia Labex, Gandhi Nagar

Reflecting these changes, Asia Labex, India's premier international exhibition and summit dedicated to laboratory technology, analysis, biotechnology, diagnostics, and chemical & consumables products is scheduled to take place from November 13 to 15 2025 at Helipad Exhibition Center, Sector 17, Gandhinagar, Gujarat.

With the theme “Laboratory & Analytical Instruments Empowering Pharma, Research, Food & Beverage Industries”, Asia Labex, Gandhi Nagar is expected to host more than 10,000 visitors and more than 300 exhibitors, more than 3,000 brands and 6,000 plus Innovative products from industries like pharma, research, food & beverages, dairy and education.

The event is expected to attract more than 10,000 professional visitors from various sectors, including pharmaceuticals, biotechnology, diagnostics, and research institutions. There will be participation from leading laboratory equipment manufacturers, suppliers, and service providers from around the world.

FLERE HISTORIER FRA Chronicle Pharmabiz

Chronicle Pharmabiz

Recent developments in Bangladesh pharma industry

Over the past four decades, the pharmaceutical industry in Bangladesh has undergone a sweeping transformation- emerging from its modest, import-dependent roots into a powerful, innovation-driven sector at the forefront of national development. What once relied heavily on foreign suppliers for basic medicines has now evolved into a self-reliant, technologically advanced industry capable of producing everything from lifesaving generics to complex oncology drugs.

time to read

7 mins

October 30, 2025

Chronicle Pharmabiz

Asia Labex showcases latest advancements in lab technology

DRIVEN by increased investment in pharmaceutical and biotech R&D, a rising need for advanced diagnostic equipment due to disease prevalence, and the growing adoption of automation in labs, the pharma laboratory equipment market has positive prospects.

time to read

6 mins

October 30, 2025

Chronicle Pharmabiz

AMMOI demands insurance for Ayurveda day care therapies

THE Ayurvedic Medicine Manufacturers Organ- isation of India (AM- MOI) has sought Union Ayush Minister Prataprao Jadhav's immediate interven- tion to ensure health insurance covers for Ayurvedic day care therapies.

time to read

2 mins

October 30, 2025

Chronicle Pharmabiz

Global API market poised for significant changes

The global API market is poised for significant transformation in the coming decade, with growth concentrated in complex APIs, biologics, peptides, and high-potency APIS (HPAPIs).

time to read

6 mins

October 30, 2025

Chronicle Pharmabiz

PvPI identifies 16 India specific signals

THE Pharmacovigilance Programme of India (PvPI) under the Indian Pharmacopoeia Commission (IPC) has identified 16 India specific signals. The same has been communicated to the Central Drugs Standard Control Organisation (CDSCO) for timely regulatory interventions towards patient safety.

time to read

2 mins

October 30, 2025

Chronicle Pharmabiz

CDSCO sets up digital system to monitor quality of solvents

THE Central Drugs Standard Control Organisation (CDSCO) has set up a Digital Monitoring System on the Online National Drugs Licensing System (ONDLS) portal to monitor the supply chain as well as quality of the high-risk solvents and has asked the State drug controllers to direct all manufacturers of pharma grade solvents to obtain manufacturing license through the portal.

time to read

2 mins

October 30, 2025

Chronicle Pharmabiz

Surgicals import grows 11.58%, exports remain stagnant in August

IMPORTS of surgical equipment to the country have reported a decline of 11.58% even as the export of these products was almost stagnant during the month of August, 2025. For the first five months of the current fiscal, imports registered almost 9% growth compared to the same period a year ago.

time to read

2 mins

October 30, 2025

Chronicle Pharmabiz

Chronicle Pharmabiz

API China focuses on innovation & global co-operation

In recent years, the scale of China's pharmaceutical active pharmaceutical ingredients (APIs) and its global market share have gradually increased. The China API market is experiencing significant growth, driven by expanding global pharmaceutical demand, an aging population, rising chronic disease rates, and the expiration of patents boosting demand for generics.

time to read

6 mins

October 30, 2025

Chronicle Pharmabiz

PVPI identifies 16 India specific signals

THE Pharmacovigilance Programme of India (PvPI) under the Indian Pharmacopoeia Commission (IPC) has identified 16 India specific signals. The same has been com- municated to the Central Drugs Standard Control Organisation (CDSCO) for timely regulatory interventions towards patient safety.

time to read

2 mins

October 30, 2025

Chronicle Pharmabiz

PM&AC 2025 redefines excellence in pharma manufacturing

THE 7th Annual Pharma Manufacturing & Automation Convention (PM&AC) 2025, co-located with the Pharma Manufacturing & Automation Excellence Awards, concluded on October 8 and 9 at Novotel HICC, Hyderabad, with resounding success.

time to read

3 mins

October 30, 2025

Listen

Translate

Share

-
+

Change font size